Our Mission is pre-clinical R&D through state-of-the-art antibody discovery, developing proprietary innovative projects and expanding the R&D pipelines of partnering pharmaceutical companies with nanobodies libraries specifically tailored to their selected targets.
CLB has its own nanobodies platform, cutting-edge in-house technologies and access to extensive facilites.
Choose Life BioTech SA ( CLB ) is an independent and innovative biotech company based in Bellinzona (CH) that operates in the nanobodies sector.
Choose Life BioTech SA aims to be a highly specialized biotech company focused on research and development using proprietary and exclusive libraries of rationally engineered nanobodies either as carriers of active payloads or active ingredients themselves.
Our Vision is to become the most sought-after company for innovative therapeutic and diagnostic solutions based on engineered nanobody advancing therapeutics from concept to clinic!
Our ambition is to catalyze innovation in drug discovery through engineered nanobodies, transforming breakthrough science into life-changing therapies.
